Criteria Capital Risc

Criteria Capital Risc is the venture capital arm of CriteriaCaixa — Spain's largest investment holding — and operates through two evergreen specialist funds: Criteria Venture Tech (technology) and Criteria Bio Ventures (biotechnology and life sciences). The firm targets a €300 million commitment through 2030, backing early-stage innovative companies primarily in Spain and Portugal, with selective reach across Europe and North America. Criteria Venture Tech backs technical founders from pre-seed to pre-Series A, focusing on deep tech, AI, cybersecurity, developer tooling, and software and data infrastructure, seeking teams that build differentiated technologies capable of generating lasting competitive advantages. Criteria Bio Ventures invests in companies developing disruptive therapeutic approaches focused on unmet medical needs, partnering with driven entrepreneurs and co-investors who aim to revolutionize healthcare through well-protected innovations. Criteria Capital Risc takes board seats and provides active operational support, with nearly 70% of current portfolio value held in Spanish companies.